Wednesday, March 31, 2021

March 31, 2021 at 11:28PM TRG Rapid Inquiry Program (TRIP)

As a result of the July 2020 update the FDA's guidance document, "Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use", FDA extended the TRIP program. It ended on March 31, 2021.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/35fzlpz

March 31, 2021 at 08:07PM Training Course: Achieving Data Quality and Integrity in Maximum Containment Laboratories

To help address challenges associated with ensuring data quality and integrity in regulated studies conducted in BSL-4 laboratories to support MCM development, FDA and UTMB collaborate to provide an annual training course on how to meet GLP requirements in BSL-4 facilities

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/30kpooc

Tuesday, March 30, 2021

March 30, 2021 at 10:24PM Database of Pharmacogenomic Information in Ethnic Minority Populations (dbPGxEMP)

Differences in genes can make someone more or less likely to benefit from a drug, suffer side effects, or require a dose that is different from other people. Such pharmacogenomic (PGx) information can be used to improve the medical decision-making process.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/39p6thH

March 30, 2021 at 07:46PM Transfusion/Donation Fatalities

This page provides details on the Notification Process for Transfusion Related Fatalities and Donation Related Deaths.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2rcvVou

Saturday, March 27, 2021

March 27, 2021 at 02:43PM FDA Approves First Cell-Based Gene Therapy for Adult Patients with Multiple Myeloma

The FDA approved Abecma, the first cell-based gene therapy to treat adult patients with multiple myeloma who have not responded to, or whose disease has returned after, at least four prior lines (different types) of therapy.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3ssDamB

March 27, 2021 at 02:05PM Approved Cellular and Gene Therapy Products

Listing of licensed and approved products from the Office of Tissues and Advanced Therapies (OTAT).

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/39nXywG

Thursday, March 25, 2021

March 25, 2021 at 08:53PM Multilingual COVID-19 Resources

The U.S. Centers for Disease Control and Prevention (CDC), and international and U.S. Government partners including FDA, are addressing an outbreak of coronavirus disease 2019 (COVID-19).

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3bey6d4

March 25, 2021 at 06:29PM Serological Reagents for the Laboratory Diagnosis of West Nile Virus - Class II Special Controls Guidance Document for Industry and FDA Staff

Developed as a special control to support the classification of the West Nile virus (WNV) serological reagents into class II (special controls).

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2TjVbDr

March 24, 2021 at 08:06PM Tissue Notices, Proposed and Final Rules

List of Tissue Notices, Proposed and Final Rules

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2Q4sd8W

Wednesday, March 24, 2021

March 24, 2021 at 11:24PM SHINGRIX

This is the main page for the CBER SHINGRIX.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3rdNC00

March 24, 2021 at 06:03PM Learn More About COVID-19 Vaccines From the FDA

Get answers to your questions about the standards for safety and effectiveness to support an emergency use authorization of COVID-19 vaccines.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2OV1UFR

Tuesday, March 23, 2021

March 23, 2021 at 07:28PM Executive Order 13944 List of Essential Medicines, Medical Countermeasures, and Critical Inputs

In consultation with other federal partners, FDA has developed a list of drug and biological product essential medicines, drug, biological product, and device medical countermeasures, and critical inputs, as required by Executive Order 13944. FDA welcomes public comment on this list.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2HMrmJO

Monday, March 22, 2021

March 22, 2021 at 03:17PM Help Stop the Spread of Coronavirus and Protect Your Family

We can each take simple steps to slow the spread of COVID-19 and protect ourselves, our families and our communities. Get a COVID-19 vaccine. Wash your hands often. Cover your mouth and nose with a mask when around others. Avoid crowds and practice social distancing.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/33Z5W4O

March 22, 2021 at 01:51PM Contacts in the Center for Biologics Evaluation & Research (CBER)

List of contact information in the Center for Biologics Evaluation & Research (CBER)

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2ONy8CT

March 19, 2021 at 07:08PM Coronavirus (COVID-19) Update: March 19, 2021

Coronavirus (COVID-19) Update: March 19, 2021

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/390i7jP

Thursday, March 18, 2021

March 15, 2021 at 06:49PM Bar Code Label Requirements

Blood and blood components must be labeled with specific machine-readable bar code information by April 26th, 2006. The purpose of the bar coding rule is to reduce transfusion errors and increase patient safety.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3eSScOL

March 17, 2021 at 10:24PM FDALabel: Full-Text Search of Drug Product Labeling

FDALabel Database is a web-based application that allows users to perform customizable searches of a database containing over 130,000 labeling documents for FDA-approved drug products, including human and animal prescription and over-the-counter drugs, biological products, and medical devices.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3qVNX7f

March 18, 2021 at 07:00PM YESCARTA (axicabtagene ciloleucel)

YESCARTA is a CD19-directed genetically modified autologous T cell immunotherapy indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy, including diffuse large B-cell lymphoma (DLBCL) not otherwise specified, primary mediastinal large B-cell lymphoma, high grade B-cell lymphoma, and DLBCL arising from follicular lymphoma.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2BbIKEt

March 17, 2021 at 05:11PM Improvement of Biological Product Quality by Application of New Technologies to Characterize of Vaccines and Blood Products: NMR Spectroscopy and Light Scattering

A description of Daron Freedberg's research program and related publications.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2DsvkVB

March 17, 2021 at 02:36PM Vaccines, Blood & Biologics

From blood to vaccines, FDA protects and advances the public health by ensuring that biological products are safe, effective, and available to those who need them. Read these Consumer Updates to learn more.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2QQ7hod

Tuesday, March 16, 2021

March 16, 2021 at 10:20PM Influenza neuraminidase antigenicity and efficacy in vaccines

Robert Daniels' research project "Influenza neuraminidase antigenicity and efficacy in vaccines".

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/30Uymdk

March 16, 2021 at 10:01PM FDA develops rapid and sensitive assay to assess antibody response to Ebola virus vaccine without using the virus

FDA develops rapid and sensitive assay to assess antibody response to Ebola virus vaccine without using the virus

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/313epBH

March 16, 2021 at 09:36PM FY 2019 Report from the Director

Fiscal Year 2019 was an exciting time at CBER, as we continued to conduct important mission-oriented research and approved important new products that protect and improve public health. These included a novel gene therapy, vaccines, treatments for immune deficiencies, and tests for protection of the

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/369ow8Z

March 16, 2021 at 09:14PM FY 2018 Report from the Director

FY 2018 Report from the Director, Dr. Peter Marks

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/328xKQ5

March 16, 2021 at 08:53PM Coronavirus (COVID-19) Update: March 16, 2021

Coronavirus (COVID-19) Update: March 16, 2021

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3lkdPss

March 16, 2021 at 06:11PM Animal Rule Information

Links to information about the Animal Rule, which may be used to grant marketing approval of certain products when human challenge studies would not be ethical or feasible

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2Law18L

March 15, 2021 at 06:49PM Bar Code Label Requirements

Blood and blood components must be labeled with specific machine-readable bar code information by April 26th, 2006. The purpose of the bar coding rule is to reduce transfusion errors and increase patient safety.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2PLkmOC

March 10, 2021 at 06:49PM Study of the regulation of blood coagulation by factors VIIa and IXa

A description of Mikhail Ovanesov's research program and related publications.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2DHtz7g

March 11, 2021 at 11:38PM Micro Typing Systems A/B; MTS A/B/D; MTS A/B/D/Reverse and MTS Monoclonal Rh Phenotype Card

Manufacture of a "Monoclonal Rh Phenotype Card"

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3qGx00B

March 11, 2021 at 11:16PM FDA Patient Engagement Opportunities

A description of some of the opportunities for patients, caregivers and advocates to engage with the FDA.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/32lI6PF

March 11, 2021 at 10:31PM MTS Anti-IgG Card

Indicated For in vitro blood banking reagent

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2Jz4Z7C

March 11, 2021 at 02:53PM MTS A/B; MTS A/B/D; MTS A/B/D/Reverse and MTS Monoclonal Rh Phenotype Card

Manufacture of a "Monoclonal Rh Phenotype Card"

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3vjorMW

March 11, 2021 at 09:06PM Remarks by FDA Chief Scientist Denise Hinton to the Professional Services Council FedHealth Conference - 03/11/2021

Remarks by FDA Chief Scientist Denise Hinton to the Professional Services Council FedHealth Conference, March 11, 2020

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3l8NVrw

Wednesday, March 10, 2021

March 10, 2021 at 10:31PM Section 8400: Marketing Applications

This is the SOPP Section 8400: Marketing Applications main page.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2U9zYMz

Monday, March 8, 2021

March 08, 2021 at 08:45PM Patient Listening Session Summaries

Patient Listening Session summaries are published after each session to share a high-level summary of the discussion. The Office of Patient Affairs draft summaries for FDA-requested sessions and the patient community requester drafts summaries for Patient-led sessions.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3v64qJv

Friday, March 5, 2021

March 05, 2021 at 09:36PM Coronavirus (COVID-19) Update: March 5, 2021

Coronavirus (COVID-19) Update: March 5, 2021

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/30f5UmD

March 05, 2021 at 01:21PM CDER Scientific Review Documents Supporting Emergency Use Authorizations for Drug and Biological Therapeutic Products | COVID-19

CDER Scientific Reviews Supporting EUA for Therapeutic Products

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3sQrJVz

Thursday, March 4, 2021

March 04, 2021 at 04:52PM Flucelvax Quadrivalent

For active immunization of children and adolescents 4 years of age and older for the prevention of disease caused by influenza A subtype viruses and type B viruses contained in the vaccine.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2REAPn2

March 03, 2021 at 08:49PM Xenotransplantation

Xenotransplantation is any procedure that involves the transplantation, implantation or infusion into a human recipient of either live cells, tissues, or organs from a nonhuman animal source, or human body fluids, cells, tissues or organs that have had ex vivo contact with live nonhuman animal cells, tissues or organs.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3jfh1Uq

March 03, 2021 at 07:51PM FDA’s Data Modernization Action Plan: Putting Data to Work for Public Health

Data modernization is the next step in the agency’s overhaul of its approach to technology and data, and we are pleased to announce the Data Modernization Action Plan (DMAP).

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2Oi0xQT

Tuesday, March 2, 2021

March 03, 2021 at 02:51AM 2021_03 Test Article FT 01

2021_03 Test Article some long description some long description.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3kFfMPF

March 02, 2021 at 09:52PM Coronavirus (COVID-19) Update: March 2, 2021

Coronavirus (COVID-19) Update: March 2, 2021

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3q7vu7n

March 02, 2021 at 08:31PM FDA Voices on Consumer Safety and Enforcement

FDA Voices on Consumer Safety and Enforcement

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3baKahQ

March 02, 2021 at 05:45PM National Consumer Protection Week: FDA Is Vigilant in Protecting Consumers Against COVID-19 Vaccine Scams

The FDA is well-equipped to identify and thwart medical product scams while vaccine distribution is underway throughout the country.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/385lBkm

March 02, 2021 at 04:48PM Update on Amyotrophic Lateral Sclerosis (ALS) Product Development

This page describes the Update on Amyotrophic Lateral Sclerosis (ALS) Product Development

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2NM5GAR

March 02, 2021 at 12:26AM Cellular & Gene Therapy Products

CBER provides oversight of clinical studies, proactive scientific and regulatory advice to medical researchers and manufacturers of cellular therapy products, human gene therapy products, and certain devices related to cell and gene therapy.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2Ap1HU3

Monday, March 1, 2021

March 01, 2021 at 07:48PM Octaplas

Product approval information is indicated for Replacement of multiple coagulation factors in patients with acquired deficiencies
o due to liver disease
o undergoing cardiac surgery or liver transplant
Plasma exchange in patients with thrombotic thrombocytopenic purpura (TTP.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3uIJRT4

March 01, 2021 at 04:32PM FDA Voices on Policy

FDA Voices on Policy

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2wZLu61

March 01, 2021 at 02:40PM Rare Disease Day 2021: FDA Shows Sustained Support of Rare Disease Product Development During the Public Health Emergency

As the FDA focuses on the COVID-19 pandemic, the agency also remains dedicated to its crucial role in development of treatments for rare diseases.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3sDU3ul